vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and WIDEPOINT CORP (WYY). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $42.3M, roughly 1.8× WIDEPOINT CORP). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 12.3%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-270.0K). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 11.2%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

WidePoint Corporation is an American company based in Fairfax, Virginia that provides technology-based products and services to the government sector and commercial markets in the United States. The company holds a patent for a digital parsing tool that allows users to access accounts through a secure repository gateway, established using asymmetric authentication employed as public key infrastructure (PKI). WidePoint provides smart card identity verification, wireless expense management, pen...

PBYI vs WYY — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.8× larger
PBYI
$75.5M
$42.3M
WYY
Growing faster (revenue YoY)
PBYI
PBYI
+15.5% gap
PBYI
27.7%
12.3%
WYY
More free cash flow
PBYI
PBYI
$14.7M more FCF
PBYI
$14.4M
$-270.0K
WYY
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
11.2%
WYY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBYI
PBYI
WYY
WYY
Revenue
$75.5M
$42.3M
Net Profit
$-849.4K
Gross Margin
69.3%
13.8%
Operating Margin
22.7%
-1.9%
Net Margin
-2.0%
Revenue YoY
27.7%
12.3%
Net Profit YoY
-138.3%
EPS (diluted)
$0.26
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
WYY
WYY
Q4 25
$75.5M
$42.3M
Q3 25
$54.5M
$36.1M
Q2 25
$52.4M
$37.9M
Q1 25
$46.0M
$34.2M
Q4 24
$59.1M
$37.7M
Q3 24
$80.5M
$34.6M
Q2 24
$47.1M
$36.0M
Q1 24
$43.8M
$34.2M
Net Profit
PBYI
PBYI
WYY
WYY
Q4 25
$-849.4K
Q3 25
$8.8M
$-559.2K
Q2 25
$5.9M
$-618.5K
Q1 25
$3.0M
$-724.1K
Q4 24
$-356.4K
Q3 24
$20.3M
$-425.2K
Q2 24
$-4.5M
$-499.6K
Q1 24
$-4.8M
$-653.1K
Gross Margin
PBYI
PBYI
WYY
WYY
Q4 25
69.3%
13.8%
Q3 25
77.7%
14.6%
Q2 25
76.5%
13.5%
Q1 25
77.1%
14.0%
Q4 24
76.4%
12.6%
Q3 24
63.9%
13.6%
Q2 24
77.4%
13.6%
Q1 24
75.5%
13.6%
Operating Margin
PBYI
PBYI
WYY
WYY
Q4 25
22.7%
-1.9%
Q3 25
17.6%
-1.3%
Q2 25
12.7%
-1.9%
Q1 25
8.7%
-2.4%
Q4 24
22.6%
-0.8%
Q3 24
27.4%
-1.3%
Q2 24
-4.6%
-1.3%
Q1 24
-5.3%
-1.9%
Net Margin
PBYI
PBYI
WYY
WYY
Q4 25
-2.0%
Q3 25
16.2%
-1.5%
Q2 25
11.2%
-1.6%
Q1 25
6.5%
-2.1%
Q4 24
-0.9%
Q3 24
25.2%
-1.2%
Q2 24
-9.6%
-1.4%
Q1 24
-11.0%
-1.9%
EPS (diluted)
PBYI
PBYI
WYY
WYY
Q4 25
$0.26
$-0.08
Q3 25
$0.17
$-0.06
Q2 25
$0.12
$-0.06
Q1 25
$0.06
$-0.08
Q4 24
$0.40
$-0.05
Q3 24
$0.41
$-0.04
Q2 24
$-0.09
$-0.05
Q1 24
$-0.10
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
WYY
WYY
Cash + ST InvestmentsLiquidity on hand
$97.5M
$9.8M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$130.3M
$11.5M
Total Assets
$216.3M
$79.8M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
WYY
WYY
Q4 25
$97.5M
$9.8M
Q3 25
$94.4M
$12.1M
Q2 25
$96.0M
$6.8M
Q1 25
$93.2M
$3.7M
Q4 24
$101.0M
$6.8M
Q3 24
$96.7M
Q2 24
$96.8M
Q1 24
$107.2M
Total Debt
PBYI
PBYI
WYY
WYY
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
PBYI
PBYI
WYY
WYY
Q4 25
$130.3M
$11.5M
Q3 25
$115.3M
$12.2M
Q2 25
$104.7M
$12.6M
Q1 25
$97.1M
$13.0M
Q4 24
$92.1M
$13.6M
Q3 24
$71.1M
$13.8M
Q2 24
$48.5M
$14.0M
Q1 24
$51.0M
$14.2M
Total Assets
PBYI
PBYI
WYY
WYY
Q4 25
$216.3M
$79.8M
Q3 25
$202.9M
$70.6M
Q2 25
$194.9M
$76.6M
Q1 25
$196.2M
$71.4M
Q4 24
$213.3M
$71.6M
Q3 24
$220.7M
$56.9M
Q2 24
$205.0M
$58.6M
Q1 24
$214.1M
$54.4M
Debt / Equity
PBYI
PBYI
WYY
WYY
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
WYY
WYY
Operating Cash FlowLast quarter
$14.4M
$-173.5K
Free Cash FlowOCF − Capex
$14.4M
$-270.0K
FCF MarginFCF / Revenue
19.1%
-0.6%
Capex IntensityCapex / Revenue
0.0%
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M
$5.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
WYY
WYY
Q4 25
$14.4M
$-173.5K
Q3 25
$9.7M
$5.9M
Q2 25
$14.1M
$3.2M
Q1 25
$3.6M
$-3.2M
Q4 24
$15.6M
$2.4M
Q3 24
$11.0M
$1.9M
Q2 24
$1.0M
$-1.1M
Q1 24
$11.2M
$-1.6M
Free Cash Flow
PBYI
PBYI
WYY
WYY
Q4 25
$14.4M
$-270.0K
Q3 25
$9.7M
$5.9M
Q2 25
$14.1M
$3.1M
Q1 25
$3.6M
$-3.3M
Q4 24
$15.6M
$2.4M
Q3 24
$11.0M
$1.8M
Q2 24
$1.0M
$-1.1M
Q1 24
$-1.6M
FCF Margin
PBYI
PBYI
WYY
WYY
Q4 25
19.1%
-0.6%
Q3 25
17.7%
16.4%
Q2 25
26.8%
8.1%
Q1 25
7.7%
-9.5%
Q4 24
26.4%
6.4%
Q3 24
13.7%
5.3%
Q2 24
2.1%
-3.0%
Q1 24
-4.6%
Capex Intensity
PBYI
PBYI
WYY
WYY
Q4 25
0.0%
0.2%
Q3 25
0.0%
0.1%
Q2 25
0.0%
0.2%
Q1 25
0.1%
0.1%
Q4 24
0.0%
0.1%
Q3 24
0.0%
0.2%
Q2 24
0.0%
0.0%
Q1 24
0.0%
0.0%
Cash Conversion
PBYI
PBYI
WYY
WYY
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PBYI
PBYI

Segment breakdown not available.

WYY
WYY

Carrier Services$26.8M63%
Managed Services$15.5M37%

Related Comparisons